Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Behavior
Researchers from University of Texas, Health Science Center publish new studies and findings in the area of behavior
April 19th, 2008
Investigators publish new data in the report 'Modulation of human risky decision making by flunitrazepam.' According to recent research from the United States, "GABA-modulating drugs produce disinhibitory effects that increase the probability of risk-taking behavior. Previous reports suggest that the misuse of the benzodiazepine flunitrazepam is associated with several forms of harmful risky behavior, including theft, violence, and intoxication-related auto accidents." "The present study examined the dose-response relationships between acute flunitrazepam administration and human decision making under conditions of risk. The analyses also examined flunitrazepam-mediated...
Source: Law & Health Weekly (2008-04-19)
|
